Clustered nanobody-drug conjugates for targeted cancer therapy

被引：18
|
作者：
Wu, Tiantian [1 ]
Liu, Manman [1 ]
Huang, Hai [1 ]
Sheng, Yaping [1 ]
Xiao, Haihua [2 ]
Liu, Yangzhong [1 ]
机构：
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Life Sci & Med, Dept Chem, Hefei 230001, Anhui, Peoples R China
[2] Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, State Key Lab Polymer Phys & Chem, Beijing 100190, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2020年 / 56卷 / 65期
基金：
美国国家科学基金会; 国家重点研发计划;
关键词：
EGFR; PEGYLATION; DELIVERY; SITE;
D O I：
10.1039/d0cc03396k
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
A clustered Nb-drug conjugate (cNDC@PEG) was designed using anti-EGFR Nb to specifically deliver Pt(iv) prodrugs to tumors. cNDC@PEG efficiently targets EGFR positive tumor cells, and the clustered cNDC@PEG is more efficient in inhibiting tumor growthin vivothan the monomeric NDC. This work provides a novel strategy for the construction of a multi-valent NDC using dendrimers.
引用
收藏
页码：9344 / 9347
页数：4
相关论文
共 50 条
  • [1] Mesothelin-targeted nanobody-drug conjugates to treat pancreatic cancer
    Dutta, N.
    Becher, J.
    Misteli, R.
    Vidal, A. Vasco
    Gomez, Y. Mendez
    Lopez, F. Corzana
    Ho, M.
    Alewine, C.
    Bernardes, G.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S68 - S68
  • [2] Modular design of nanobody-drug conjugates for targeted-delivery of platinum anticancer drugs with an MRI contrast agent
    Huang, Hai
    Wu, Tiantian
    Shi, Hongdong
    Wu, Yun
    Yang, Hongyi
    Zhong, Kai
    Wang, Yucai
    Liu, Yangzhong
    CHEMICAL COMMUNICATIONS, 2019, 55 (35) : 5175 - 5178
  • [3] GALA peptide improves the potency of nanobody-drug conjugates by lipid-induced helix formation
    Chen, Ya Jie
    Deng, Qi Wen
    Wang, Li
    Guo, Xiao Chun
    Yang, Jian Yuan
    Li, Ting
    Xu, Zhengshuang
    Lee, Hon Cheung
    Zhao, Yong Juan
    CHEMICAL COMMUNICATIONS, 2021, 57 (12) : 1434 - 1437
  • [4] Nanobody-photosensitizer conjugates for targeted photodynamic therapy
    Heukers, Raimond
    Henegouwen, Paul M. P. van Bergen en
    Oliveira, Sabrina
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2014, 10 (07) : 1441 - 1451
  • [5] Antibody-Drug Conjugates for Targeted Cancer Therapy
    Goldmacher, Victor S.
    Chittenden, Thomas
    Chari, Ravi V. J.
    Kovtun, Yelena V.
    Lambert, John M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 349 - 366
  • [6] A promising MET-EGFR bispecific nanobody-drug conjugate therapy for multiple solid tumours
    Cai, X.
    Wu, G.
    Ju, D.
    Zhang, C.
    Yu, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S810 - S810
  • [7] Structurally Defined aMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma
    Fang, Tao
    Duarte, Joao N.
    Ling, Jingjing
    Li, Zeyang
    Guzman, Jonathan S.
    Ploegh, Hidde L.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (07) : 2416 - 2420
  • [8] Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells
    Zavoiura, Oleksandr
    Brunner, Bodo
    Casteels, Peter
    Zimmermann, Luciana
    Ozog, Matthias
    Boutton, Carlo
    Helms, Mike W.
    Wagenaar, Timothy
    Adam, Volker
    Peterka, Josefine
    Metz-Weidmann, Christiane
    Deschaght, Pieter
    Scheidler, Sabine
    Jahn-Hofmann, Kerstin
    MOLECULAR PHARMACEUTICS, 2021, 18 (03) : 1048 - 1060
  • [9] Peptide-drug conjugates: A new paradigm for targeted cancer therapy
    Wang, Mo
    Liu, Jiawei
    Xia, Mingjing
    Yin, Libinghan
    Zhang, Ling
    Liu, Xifu
    Cheng, Yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265
  • [10] Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
    Aggarwal, Devesh
    Yang, Jie
    Salam, Md. Abdus
    Sengupta, Sagnik
    Al-Amin, Md. Yusuf
    Mustafa, Saad
    Khan, Mohammad Aasif
    Huang, Xun
    Pawar, Jogendra Singh
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345